Precision Medicine and the FDA

Policy researchers and biotechnology executives talked about Food and Drug Administration (FDA) approval process. The panelists focused on… read more

Precision Medicine and the FDA Policy researchers and biotechnology executives talked about Food and Drug Administration (FDA) approval process. The panelists focused on precision medicine, which tailors treatments to the specific biochemistry of patients. The Manhattan Institute put out a paper in 2015 that showed the FDA was slow to approve new methods. close

People in this video

  • Paul Howard Senior Fellow and Director Manhattan Institute for Policy Research->Center for Medical Progress
  • Peter W. Huber Senior Fellow Manhattan Institute for Policy Research
More People

Hosting Organization

More information about

Precision Medicine and the FDA

204 Views
Program ID:
325299-1
Category:
Public Affairs Event
Format:
Forum
Location:
New York, New York, United States
First Aired:
Sep 01, 2015 | 10:42am EDT | C-SPAN 1
Last Aired:
Dec 24, 2015 | 9:37am EST | C-SPAN 2

Airing Details

  • Sep 01, 2015 | 10:42am EDT | C-SPAN 1
  • Sep 04, 2015 | 5:15am EDT | C-SPAN 1
  • Sep 25, 2015 | 3:31am EDT | C-SPAN 2
  • Nov 21, 2015 | 10:05pm EST | C-SPAN 1
  • Nov 22, 2015 | 1:15am EST | C-SPAN 1
  • Dec 23, 2015 | 4:28pm EST | C-SPAN 2
  • Dec 24, 2015 | 9:37am EST | C-SPAN 2
Purchase a DVD or Download

Precision Medicine and the FDA

  • DVD
    Price:
    $29.95
  • MP3 audio - Standard
    Price:
    $0.99